SEC ownership of ANAPTYSBIO, INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001370053.

Comparable stake leader

EcoR1 Capital, LLC

Disclosed value leader

EcoR1 Capital, LLC

Comparable rows

10/50

Latest evidence

16 Nov 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
10 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
EcoR1 Capital, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
16 Nov 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001370053
Issuer location
San Diego, CA

Ownership snapshot

Top shareholders of ANAPTYSBIO, INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
10/50
Latest evidence
16 Nov 2026
13D/G 3/4/5 13F Lead comparable stake: 28% 40 rows are not safely comparable across share classes. 13D/G row: EcoR1 Capital, LLC Showing 1-8 of 50 holder rows.

Quick read

EcoR1 Capital, LLC leads the comparable SEC ownership view at 28%.

10 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens EcoR1 Capital, LLC's linked filing trail.
Comparable ownership Top 5
EcoR1 Capital, LLC 28%
BlackRock, Inc. 6.2%
GOLDMAN SACHS GROUP INC 4.5%
MORGAN STANLEY 3.6%
First Light Asset Management, LLC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EcoR1 Capital, LLC
13D/G 3/4/5 13F
Director, 10%+ Owner · Company
28%
Reported 13D/G · 16 Nov 2026
$400,599,329
8,254,674 shares
$0 16 Nov 2026
BlackRock, Inc.
13D/G
6.2%
Reported 13D/G · 31 Mar 2025
$39,347,471
1,900,844 shares
-$13,405,817 31 Mar 2025
GOLDMAN SACHS GROUP INC
13F 13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
4.5%
Reported 13D/G · 30 Sep 2025
$42,738,238
850,343 shares
— 30 Sep 2026
MORGAN STANLEY
13D/G 13F
Company
3.6%
Reported 13D/G · 31 Dec 2025
$45,484,108
1,006,063 shares
-$37,928,432 31 Dec 2025
First Light Asset Management, LLC
13D/G 13F
Mathew P. Arens · Company
3.1%
Reported 13D/G · 30 Sep 2025
$26,474,603
864,618 shares
-$42,907,347 30 Sep 2025
Sirenia Capital Management LP
13D/G
3.1%
Reported 13D/G · 30 Sep 2026
$44,872,779
924,640 shares
-$27,531,991 30 Sep 2026
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
2.9%
Reported 13D/G · 31 Dec 2025
$39,442,003
813,571 shares
-$29,733,912 31 Dec 2025
FMR LLC
13D/G
0.9%
Reported 13D/G · 30 May 2025
$5,091,861
254,212 shares
-$33,068,368 30 May 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$24,697,080.

Buys
$34,449,186
Insiders: 2
Sells
$9,752,105
Insiders: 8
Net
+$24,697,080
Shares: +549,556
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 749,160 Shares: 199,604
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 749,160 5,000 $34,449,186 $249,372 +$34,199,814
3-6 0 0 $0 $0 $0
6-9 0 38,324 $0 $2,247,650 -$2,247,650
9-12 0 156,280 $0 $7,255,084 -$7,255,084

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-19 of 19 reporting-owner rows connected to ANAPTYSBIO, INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
19
Largest Forms 3/4/5 holder
Oleg Nodelman
Net 12M change
+$24.7MFull value: +$24,697,080 · USD · 12-month change
Latest report
16 Nov 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Oleg Nodelman Director, 10%+ Owner $384,188,211 +$17,224,593 +4.7% Filing P/S 16 Nov 2026
EcoR1 Capital, LLC Director, 10%+ Owner $384,188,211 +$17,224,593 +4.7% Filing P/S 16 Nov 2026
Daniel Faga President, CEO, Director $34,118,977 -$2,805,072 -7.6% Mixed 20 Apr 2026
Paul F. Lizzul Chief Medical Officer $2,403,484 -$521,526 -18% Mixed 12 Mar 2026
John P. Schmid Director $2,180,438 -$1,158,451 -35% Mixed 15 Jun 2026
Dennis Mulroy Chief Financial Officer $1,387,042 -$1,549,332 -53% Mixed 07 Jan 2026
John A. Orwin Director $1,306,921 Mixed 15 Sep 2026
Eric J. Loumeau Chief Legal Officer $1,053,405 -$2,744,479 -72% Mixed 11 Feb 2026
Hollings Renton Director $640,626 -$249,372 -28% Mixed 01 Oct 2026
Magda Marquet Director $577,329 -$530,531 -48% Mixed 15 Jan 2026
J. Anthony Ware Director $569,666 -$193,343 -25% Mixed 06 Jan 2026
Rita Jain Director $359,910 Mixed 06 Jan 2026
Dennis M. Fenton Director $211,270 Mixed 06 Jan 2026
Laura Jean Hamill Director $85,059 Mixed 06 Jan 2023
James N. Topper Director, 10%+ Owner $85,059 Mixed 06 Jan 2023
Hamza Suria President, CEO, Director Mixed 10 Feb 2022
Owen Hughes Director Mixed 11 May 2026
Susannah Gray Director Mixed 27 Apr 2026
Christopher M. Murphy Chief Financial Officer Mixed 11 May 2026

Recent insider transactions for ANAPTYSBIO, INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.7% $6,427,111 $46.54 138,093 8,254,674 18 Nov 2026 See Note
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.7% $6,427,111 $46.54 138,093 8,254,674 18 Nov 2026 See Note
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.91% $6,956,361 $45.66 152,367 8,116,581 17 Nov 2026 See Note
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.91% $6,956,361 $45.66 152,367 8,116,581 17 Nov 2026 See Note
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.07% $3,841,121 $45.66 84,120 7,964,214 16 Nov 2026 See Note
EcoR1 Capital, LLC ANAB Common Stock Purchase 1.07% $3,841,121 $45.66 84,120 7,964,214 16 Nov 2026 See Note
Hollings Renton ANAB Common Stock Sale -31.3% -$249,372 $49.87 -5,000 10,995 01 Oct 2026 Direct
Hollings Renton ANAB Common Stock Options Exercise 45.5% 5,000 15,995 01 Oct 2026 Direct
Hollings Renton ANAB Common Stock Options Exercise -33.3% -5,000 10,000 01 Oct 2026 Direct
John A. Orwin ANAB Common Stock Options Exercise 7.79% 1,300 17,995 15 Sep 2026 Direct
John A. Orwin ANAB Restricted Stock Unit Options Exercise -100% -1,300 0 15 Sep 2026 Direct
John P. Schmid ANAB Common Stock Options Exercise 19.1% 6,030 37,652 15 Jun 2026 Direct
John P. Schmid ANAB Restricted Stock Unit Options Exercise -100% -6,030 0 15 Jun 2026 Direct
Hollings Renton ANAB Common Stock Options Exercise 121.4% 6,030 10,995 15 Jun 2026 Direct
Hollings Renton ANAB Restricted Stock Unit Options Exercise -100% -6,030 0 15 Jun 2026 Direct
John A. Orwin ANAB Common Stock Options Exercise 56.5% 6,030 16,695 15 Jun 2026 Direct
John A. Orwin ANAB Restricted Stock Unit Options Exercise -100% -6,030 0 15 Jun 2026 Direct
Owen Hughes ANAB Restricted Stock Units Award 11,250 11,250 11 May 2026 Direct
Christopher M. Murphy ANAB Restricted Stock Units Award 25,765 25,765 11 May 2026 Direct
Susannah Gray ANAB Restricted Stock Unit Award 11,250 11,250 27 Apr 2026 Direct
Daniel Faga ANAB Employee Stock Option (right to buy) Disposed to Issuer -50% -11,000 11,000 20 Apr 2026 Direct
John A. Orwin ANAB Stock Option (right to buy) Award 38,671 16,510 20 Apr 2026 Direct
John A. Orwin ANAB Stock Option (right to buy) Disposed to Issuer -92.1% -38,671 3,311 20 Apr 2026 Direct
John P. Schmid ANAB Stock Option (right to buy) Award 73,810 16,510 20 Apr 2026 Direct
John P. Schmid ANAB Stock Option (right to buy) Disposed to Issuer -93.1% -73,810 5,500 20 Apr 2026 Direct
Hollings Renton ANAB Stock Option (right to buy) Award 73,810 16,510 20 Apr 2026 Direct
Hollings Renton ANAB Stock Option (right to buy) Disposed to Issuer -93.1% -73,810 5,500 20 Apr 2026 Direct
John P. Schmid ANAB Common Stock Sale -39.5% -$1,158,451 $56.11 -20,645 31,622 30 Mar 2026 Direct
Daniel Faga ANAB Common Stock Sale -3.44% -$1,089,199 $61.61 -17,679 495,965 27 Mar 2026 Direct
Daniel Faga ANAB Common Stock Award 7.16% 34,300 513,644 25 Mar 2026 Direct
Paul F. Lizzul ANAB Performance Stock Units Award 16,667 16,667 12 Mar 2026 Direct
Daniel Faga ANAB Performance Stock Units Award 53,334 53,334 12 Mar 2026 Direct
Eric J. Loumeau ANAB Common Stock Sale -43.8% -$540,000 $54.00 -10,000 12,835 11 Feb 2026 Direct
Eric J. Loumeau ANAB Common Stock Options Exercise 77.9% 10,000 22,835 11 Feb 2026 Direct
Eric J. Loumeau ANAB Employee Stock Option (right to buy) Options Exercise -22.2% -10,000 35,000 11 Feb 2026 Direct
Magda Marquet ANAB Common Stock Sale -52.6% -$530,531 $48.23 -11,000 9,930 15 Jan 2026 Direct
Magda Marquet ANAB Common Stock Options Exercise 110.8% 11,000 20,930 15 Jan 2026 Direct
Magda Marquet ANAB Stock Option (right to buy) Options Exercise -100% -11,000 0 15 Jan 2026 Direct
Paul F. Lizzul ANAB Common Stock Sale -7.98% -$163,192 $44.71 -3,650 42,088 08 Jan 2026 Direct
Dennis Mulroy ANAB Common Stock Sale -10.3% -$112,446 $44.71 -2,515 21,852 08 Jan 2026 Direct
Eric J. Loumeau ANAB Common Stock Sale -14.7% -$98,809 $44.71 -2,210 12,835 08 Jan 2026 Direct
Daniel Faga ANAB Common Stock Sale -2.89% -$638,504 $44.71 -14,281 479,344 08 Jan 2026 Direct
Paul F. Lizzul ANAB Common Stock Options Exercise 22.9% 8,525 45,738 07 Jan 2026 Direct
Paul F. Lizzul ANAB Restricted Stock Unit Options Exercise -25% -8,525 25,575 07 Jan 2026 Direct
Dennis Mulroy ANAB Common Stock Options Exercise 37.9% 6,700 24,367 07 Jan 2026 Direct
Dennis Mulroy ANAB Restricted Stock Unit Options Exercise -25% -6,700 20,100 07 Jan 2026 Direct
Eric J. Loumeau ANAB Common Stock Options Exercise 64.3% 5,888 15,045 07 Jan 2026 Direct
Eric J. Loumeau ANAB Restricted Stock Unit Options Exercise -25% -5,888 17,662 07 Jan 2026 Direct
Daniel Faga ANAB Common Stock Options Exercise 5.75% 26,838 493,625 07 Jan 2026 Direct
Daniel Faga ANAB Restricted Stock Unit Options Exercise -25% -26,838 80,512 07 Jan 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .